TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

CYTK LAWSUIT ALERT: Levi & Korsinsky Notifies Cytokinetics, Incorporated Investors of a Class Action Lawsuit and Upcoming Deadline

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Levi & Korsinsky, Llp
CYTK LAWSUIT ALERT: Levi & Korsinsky Notifies Cytokinetics, Incorporated Investors of a Class Action Lawsuit and Upcoming Deadline

A class action lawsuit has been filed against Cytokinetics alleging securities fraud related to misleading statements about the New Drug Application submission and approval process for aficamten, potentially impacting investor stock prices.

Insights
ORCL   neutral

Mentioned as a tenant of Digital Realty Trust's data centers, no specific performance analysis provided


CYTK   negative

The lawsuit alleges the company made false and misleading statements about its drug approval timeline, potentially causing investors significant financial losses